Medindia
Medindia LOGIN REGISTER
Advertisement

Caliper Life Sciences' Third Quarter 2007 Financial Results Conference Call Notice

Friday, November 2, 2007 General News
Advertisement
HOPKINTON, Mass., Nov. 1 Caliper Life Sciences,Inc. (Nasdaq: CALP) will conduct a conference call discussing the company'sthird quarter 2007 financial results at 9:00 a.m. EST on Wednesday, November7, 2007. Kevin Hrusovsky, President and Chief Executive Officer and TomHiggins, Chief Financial Officer, will host the call. Management will discussoperational and financial results and the company's outlook for the future.
Advertisement

A news release discussing Caliper's third quarter 2007 financial resultswill be issued Wednesday, November 7, at approximately 7:00 a.m. EST.

Participants, please call 888-680-0869 five to ten minutes prior to thecall and use the participant passcode of 24722133. International callers canaccess the call by dialing 617-213-4854 and entering the same passcode. Youmay also pre-register for the call athttps://www.theconferencingservice.com/prereg/key.process?key=PRDRQ7FGB.
Advertisement

A live webcast of the call can be accessed at www.fulldisclosure.com or onthe Caliper website at www.caliperLS.com in the Events section of the InvestorRelations page. A webcast replay of the call will remain available untilCaliper's earnings call for the fourth quarter of 2007.

Telephone replays of the conference call will be available approximatelytwo hours after the completion of the call. To access a telephone playback ofthe proceedings from November 7 through November 14, dial 888-286-8010 and usethe participant passcode of 17240306. International callers can access theplayback by dialing 617-801-6888 and using the same participant passcode.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologiesenabling researchers in the life sciences industry to create life-saving andenhancing medicines and diagnostic tests more quickly and efficiently. Caliperis aggressively innovating new technology to bridge the gap between in vitroassays and in vivo results and then translating those results into cures forhuman disease. Caliper's portfolio of offerings includes state-of-the-artmicrofluidics, lab automation & liquid handling, optical imaging technologies,and discovery & development outsourcing solutions. For more information pleasevisit http://www.caliperLS.com.

SOURCE Caliper Life Sciences, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close